158 related articles for article (PubMed ID: 8136021)
1. Studies on the specificity of HIV protease: an application of Markov chain theory.
Chou KC; Zhang CT
J Protein Chem; 1993 Dec; 12(6):709-24. PubMed ID: 8136021
[TBL] [Abstract][Full Text] [Related]
2. An alternate-subsite-coupled model for predicting HIV protease cleavage sites in proteins.
Zhang CT; Chou KC
Protein Eng; 1994 Jan; 7(1):65-73. PubMed ID: 8140096
[TBL] [Abstract][Full Text] [Related]
3. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins.
Chou KC
J Biol Chem; 1993 Aug; 268(23):16938-48. PubMed ID: 8349584
[TBL] [Abstract][Full Text] [Related]
4. A vector projection approach to predicting HIV protease cleavage sites in proteins.
Chou KC; Zhang CT; Kézdy FJ
Proteins; 1993 Jun; 16(2):195-204. PubMed ID: 8332607
[TBL] [Abstract][Full Text] [Related]
5. Prediction of human immunodeficiency virus protease cleavage sites in proteins.
Chou KC
Anal Biochem; 1996 Jan; 233(1):1-14. PubMed ID: 8789141
[TBL] [Abstract][Full Text] [Related]
6. Support Vector Machines for predicting HIV protease cleavage sites in protein.
Cai YD; Liu XJ; Xu XB; Chou KC
J Comput Chem; 2002 Jan; 23(2):267-74. PubMed ID: 11924738
[TBL] [Abstract][Full Text] [Related]
7. Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach.
Chou JJ
J Protein Chem; 1993 Jun; 12(3):291-302. PubMed ID: 8397787
[TBL] [Abstract][Full Text] [Related]
8. Artificial neural network method for predicting HIV protease cleavage sites in protein.
Cai YD; Yu H; Chou KC
J Protein Chem; 1998 Oct; 17(7):607-15. PubMed ID: 9853675
[TBL] [Abstract][Full Text] [Related]
9. Activities of precursor and tethered dimer forms of HIV proteinase.
Phylip LH; Griffiths JT; Mills JS; Graves MC; Dunn BM; Kay J
Adv Exp Med Biol; 1995; 362():467-72. PubMed ID: 8540359
[No Abstract] [Full Text] [Related]
10. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
[TBL] [Abstract][Full Text] [Related]
11. Synergistic binding of inhibitors to the protease from HIV type 1.
Asante-Appiah E; Chan WW
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):113-7. PubMed ID: 8670094
[TBL] [Abstract][Full Text] [Related]
12. Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.
Rosé JR; Salto R; Craik CS
J Biol Chem; 1993 Jun; 268(16):11939-45. PubMed ID: 8505318
[TBL] [Abstract][Full Text] [Related]
13. Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.
Chou KC; Tomasselli AG; Reardon IM; Heinrikson RL
Proteins; 1996 Jan; 24(1):51-72. PubMed ID: 8628733
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of HIV-1 protease.
Meek TD
J Enzyme Inhib; 1992; 6(1):65-98. PubMed ID: 1285304
[TBL] [Abstract][Full Text] [Related]
15. A formulation for correlating properties of peptides and its application to predicting human immunodeficiency virus protease-cleavable sites in proteins.
Chou JJ
Biopolymers; 1993 Sep; 33(9):1405-14. PubMed ID: 8400033
[TBL] [Abstract][Full Text] [Related]
16. Subsite preferences of retroviral proteinases.
Dunn BM; Gustchina A; Wlodawer A; Kay J
Methods Enzymol; 1994; 241():254-78. PubMed ID: 7854181
[No Abstract] [Full Text] [Related]
17. HIV protease: a novel chemotherapeutic target for AIDS.
Huff JR
J Med Chem; 1991 Aug; 34(8):2305-14. PubMed ID: 1875332
[No Abstract] [Full Text] [Related]
18. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
